
By providing real‑time, anonymized menstrual data, Emm could shorten the years‑long diagnostic lag for disorders like endometriosis and open a new data source for reproductive health research, positioning the startup as a potential disruptor in the femtech market.
UK‑based femtech startup Emm announced a $9 million seed round led by Lunar Ventures, with participation from Alumni Ventures and BlueLion Global. The funding will support the product launch in the UK next year and future expansion into the US market.
Comments
Want to join the conversation?
Loading comments...